These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 360061)

  • 21. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
    Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
    Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nystatin and chlorhexidine digluconate on Candida albicans.
    Barkvoll P; Attramadal A
    Oral Surg Oral Med Oral Pathol; 1989 Mar; 67(3):279-81. PubMed ID: 2648241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of quenching agents on the activity of nystatin against Candida albicans.
    Elkhouly AE
    Mykosen; 1978 Sep; 21(9):300-6. PubMed ID: 360059
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies in vitro on the susceptibility of yeast-like fungi of Candida genus to nystatin].
    Pekowski M; Gwieździński Z; Kozlowski J
    Przegl Dermatol; 1972; 59(3):365-71. PubMed ID: 4559291
    [No Abstract]   [Full Text] [Related]  

  • 26. Nystatin antifungal micellar systems on endotracheal tubes: development, characterization and
    Benavent C; García-Herrero V; Torrado C; Torrado-Santiago S
    Pharmazie; 2019 Jan; 74(1):34-38. PubMed ID: 30782248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the morphofunctional alterations produced by fenticonazole on strains of Candida albicans, using the scanning electron microscope (S.E.M).
    Costa AL; Valenti A; Veronese M
    Mykosen; 1984 Jan; 27(1):29-35. PubMed ID: 6366540
    [No Abstract]   [Full Text] [Related]  

  • 28. Disappearance of nystatin resistance in Candida mediated by ergosterol.
    Mas J; Piña E
    J Gen Microbiol; 1980 Mar; 117(1):249-52. PubMed ID: 6993624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of nystatin].
    Gross U; Gross W
    Arch Dermatol Forsch; 1972; 242(4):389-97. PubMed ID: 4553748
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination Therapy of Clinically Approved Antifungal Drugs Is Enhanced by Conjugation with Silver Nanoparticles.
    Hussain MA; Ahmed D; Anwar A; Perveen S; Ahmed S; Anis I; Shah MR; Khan NA
    Int Microbiol; 2019 Jun; 22(2):239-246. PubMed ID: 30810990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
    Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
    J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparative in vitro study of the nystatin and amphotericin B sensitivity of strains of the fungus Candida albicans isolated from the birth canals of pregnant women, and a determination of the frequency of the presence of this microorganism in it].
    Kukharski S; Ruzhevitska M
    Antibiotiki; 1974 Feb; 19(2):178-81. PubMed ID: 4618756
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
    Bueno MG; Urban VM; Barbério GS; da Silva WJ; Porto VC; Pinto L; Neppelenbroek KH
    Oral Dis; 2015 Jan; 21(1):57-65. PubMed ID: 24219354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of chlorhexidine on budding Candida albicans: scanning and transmission electron microscopic study.
    Bobichon H; Bouchet P
    Mycopathologia; 1987 Oct; 100(1):27-35. PubMed ID: 3317060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 37. Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 Aug; 27(7):325-32. PubMed ID: 9725570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida resistant to nystatin becomes sensitive upon culture with ergosterol.
    Mas J; Piña E
    Arch Invest Med (Mex); 1985; 16(2):145-55. PubMed ID: 3907567
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipid composition and polyene antibiotic sensitivity in isolates of Candida albicans.
    Singh M; Jayakumar A; Prasad R
    Microbios; 1979; 24(95):7-17. PubMed ID: 393957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some characteristics of nystatin-resistant sterol mutants of Candida albicans.
    Pesti M; Paku S; Novák EK
    Acta Microbiol Acad Sci Hung; 1982; 29(1):55-66. PubMed ID: 7046355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.